TENAX THERAPEUTICS, INC. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tenax Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • Tenax Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Tenax Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $6.57K, a 53.3% increase year-over-year.
  • Tenax Therapeutics, Inc. annual Depreciation for 2023 was $7.57K, a 47.2% increase from 2022.
  • Tenax Therapeutics, Inc. annual Depreciation for 2022 was $5.14K, a 25% increase from 2021.
  • Tenax Therapeutics, Inc. annual Depreciation for 2021 was $4.12K, a 0.96% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.57K +$2.43K +47.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $5.14K +$1.03K +25% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $4.12K +$39.00 +0.96% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $4.08K -$940 -18.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $5.02K -$4K -44.3% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-16
2018 $9.02K -$4.61K -33.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $13.6K -$5.33K -28.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $19K Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2014 $77.8K -$10.5K -11.9% May 1, 2014 Apr 30, 2015 10-K 2017-03-16
2013 $88.3K -$4.66K -5.01% May 1, 2013 Apr 30, 2014 10-K 2017-03-16
2012 $93K May 1, 2012 Apr 30, 2013 10-KT 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.